Abstract
Introduction
Primary congenital glaucoma causes vision loss if intraocular pressure is uncontrolled. Nonpenetrating deep sclerectomy is effective in treating primary congenital glaucoma. However, the effects of inadvertent trabeculodescemetic window perforation remain unclear.
Methods
This retrospective cohort study included patients with primary congenital glaucoma who underwent nonpenetrating deep sclerectomy between 2014 and 2021. The perforation group had intraoperative trabeculodescemetic window perforations; the non-perforation group did not. The primary outcome was intraocular pressure between the groups over 15 months. The secondary outcomes included surgical success and complications.
Results
The study included 74 eyes of 44 patients. The cohort comprised 31 perforated and 43 non-perforated eyes. Both groups showed significant intraocular pressure reduction without significant between-group differences in complete (68 vs. 77%), qualified (19 vs. 9%), or failed (13 vs. 14%) treatments. The median intraocular pressure decreased from 39 to 14 mmHg in the perforation group and 35 to 12 mmHg in the non-perforation group. Of the 74 treated eyes, 68 (92%) showed no complications.
Conclusions
An inadvertent trabeculodescemetic window perforation during nonpenetrating deep sclerectomy for primary congenital glaucoma did not significantly affect intraocular pressure outcomes compared to non-perforated cases over 15 months. Nonpenetrating deep sclerectomy reduced intraocular pressure regardless of intraoperative perforation in patients with primary congenital glaucoma. Perforation of the trabeculodescemetic window was associated with a low incidence of postoperative complications.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Why carry out this study? |
Nonpenetrating deep sclerectomy (NPDS) is an effective surgical technique for reducing intraocular pressure (IOP) in pediatric patients with primary congenital glaucoma (PCG). |
The effect of inadvertent intraoperative trabeculodescemetic window (TDW) perforation during NPDS on long-term IOP control in PCG remains unclear. |
What was learned from the study? |
This retrospective cohort study compared IOP outcomes between patients with PCG and inadvertent TDW perforation and those without perforation during NPDS. |
Over 15 months, the perforation and non-perforation groups showed significant IOP reduction from baseline but no significant between-group differences in IOP or surgical success rates. |
Inadvertent TDW perforation during NPDS does not significantly affect the long-term IOP outcomes in pediatric patients with PCG. |
Introduction
Primary congenital glaucoma (PCG) is a significant cause of childhood blindness in Saudi Arabia, having an estimated prevalence ten times greater than that in Western countries. The high rate likely relates to consanguinity; increased CYP1B1 mutations predispose individuals to more severe forms of PCG [1,2,3,4].
PCG involves increased intraocular pressure (IOP) due to the abnormal development of the eye’s drainage system. Obstructed drainage can damage the optic nerve and impair vision if not addressed. Studies have evaluated different surgical procedures, such as trabeculotomy, trabeculectomy, and goniotomy, for treating PCG; these procedures are the most common treatments for this condition [5,6,7]. Unlike in Western countries, preferred interventions have not demonstrated favorable outcomes in Saudi Arabia, including goniotomy, trabeculotomy, and trabeculectomy [8,9,10,11]. Conversely, nonpenetrating deep sclerectomy (NPDS) has demonstrated promising outcomes, improving the safety of conventional filtering procedures [12].
Trabeculectomy and NPDS attempt to bypass outflow resistance by shunting the aqueous humor from the anterior chamber. Trabeculectomy effectively functions as a careful full-thickness removal of the trabecular meshwork (TM), creating a sclerostomy anterior to the TM and Schlemm canal (SC), allowing free flow of fluid into the open lumen of the SC, bypassing trabecular resistance. Creating a fistula between the anterior chamber and subconjunctival space bypasses the conventional and uveoscleral pathways [13]. NPDS involves creating a deep scleral flap to expose the underlying sclera, thereby unroofing the SC, removing its inner wall along the juxtacanalicular meshwork, and eliminating the site of maximum aqueous outflow resistance. This technique aims to preserve the integrity of uveal and corneoscleral tissues to reduce IOP without entering the anterior chamber [14].
Compared with other glaucoma surgeries, NPDS avoids perforation and reduces complications [5, 15]. However, accidental trabeculodescemetic window (TDW) perforations can occur, especially while learning the procedure [14, 16]. In deep sclerectomy, microperforation refers to a controlled, small-scale perforation of the trabeculo-Descemet membrane (TDM) during the surgical procedure. This perforation allows the aqueous humor to gradually egress through the trabeculo-Descemet’s window (TDW), helping reduce IOP without causing severe hypotony or hypotony-related complications [14, 17, 18].
Microperforation has been linked to various surgical procedures, including deep sclerectomy, phacoemulsification, and cyclophotocoagulation, and has been found to reduce IOP [19,20,21]. The mechanisms through which microperforations reduce IOP include transscleral flow, the opening of nonfunctional areas of the SC, and uveoscleral outflow [19]. The efficacy of microperforations for significantly reducing IOP has been demonstrated [22]. In addition, using microperforations is associated with an effective decrease in IOP in medium-term follow-up, suggesting potential as a long-term solution for managing glaucoma [17].
Inadvertent perforation, also known as macroperforation, during deep sclerectomy, refers to an unintended and larger-scale perforation of the trabeculo-Descemet membrane (TDM) with or without iris prolapse that occurs during the surgical procedure. This perforation can result in uncontrolled aqueous humor outflow, potentially leading to hypotony and other related complications. Studies report a 30% conversion rate to trabeculectomy or unintentional perforations [23]. The documented occurrence of inadvertent perforation during deep sclerectomy emphasizes the need for careful surgical techniques to minimize their risk [24]. Cheng et al. have proposed that inadvertent ruptures in the juxtacanalicular tissue and the inner wall of SC are potential routes for aqueous humor entry following perforations, underscoring the significance of inadvertent perforations on postoperative outcomes [25].
Few studies have compared the effects of macroperforation on IOP after NPDS. The effect of inadvertent intraoperative NPDS perforation on long-term IOP in patients with PCG remains unclear, with conflicting evidence. Lükes et al. found increased IOP after TDW perforation in patients with PCG undergoing NPDS [26]. Conversely, other studies have shown long-term efficacy and safety between penetrating deep sclerectomy and traditional NPDS [27,28,29].
Despite the promising outcomes of perforation during NPDS, critical knowledge gaps exist for the specific effects of inadvertent TDW perforation on long-IOP reduction in pediatric patients with PCG. Prior analyses have focused on other populations, mentioned this complication only secondarily, or compared different procedures rather than directly investigating the effect of TDW perforation after NPDS, specifically for PCG [30, 31]. This lack of evidence on the effects of accidental perforation during NPDS for PCG highlights this issue, especially given the devastating vision loss that PCG can cause if IOP is not well controlled. Analyzing the effect of inadvertent perforation during NPDS for PCG on postoperative IOP will provide clinically useful data for guiding surgical choices and handling complications during NPDS in these patients. Therefore, we aimed to compare IOP outcomes after NPDS with and without inadvertent perforation in pediatric PCG cases.
Methods
Study Design
This retrospective observational cohort study was conducted at the King Khaled Eye Specialist Hospital (KKESH) in Riyadh, Saudi Arabia, on children with PCG who initially underwent NPDS. The study comprised two cohorts: patients who developed TDW perforation during surgery (perforation group) and patients who did not experience perforation (nonperforation group). The study period spanned from June 2014 to June 2021. The study’s primary outcome was comparing the IOP between the two cohorts at various time points before surgery, during the follow-up period, and 15 months after surgery to determine the effect of perforation on IOP. The procedure’s success in achieving the target IOP reduction was determined using three parameters: absolute success, defined as IOP readings < 21 mmHg without any antiglaucoma medications or further surgeries; qualified success, defined as IOP readings of 6–21 mmHg with antiglaucoma medications; and failure, defined as IOP readings > 21 mmHg, even with medications. Survival analysis was conducted to quantify the risk of failure in both groups, with IOP as the secondary outcome.
Ethical Considerations
This study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments, and was approved by the Institutional Review Board of King Khaled Eye Specialist Hospital (Protocol RP 23032-R). The requirement for informed consent was waived by the institutional review board as this is a retrospective study using de-identified data from existing medical records.
Data Collection
The study conducted a thorough analysis of the electronic medical records to identify patients diagnosed with PCG and to distinguish those who underwent NPDS and subsequently developed perforation from those who did not. Therefore, consecutive patients in each group were carefully selected for further examination. The collected data were recorded in a predesigned coded data sheet and then transferred to Stata version 17 (StataCorp LLC; College Station, TX, USA) statistical software for analysis. The sample size calculation for this study was performed using Epi Info 7.2.2.2 (Centers for Disease Control and Prevention, Atlanta, GA, USA). The study used an unmatched cohort design with a two-sided confidence level of 95%, a ratio of unexposed to exposed individuals of 1.5, a power of 80%, and an estimated baseline incidence of 50%. Based on these parameters, a sample size of 70 eyes was selected: 28 in the perforation group and 42 in the non-perforation group. A post hoc power analysis was conducted based on the IOP values observed in the 31 perforated and 43 non-perforated eyes to determine whether our study was adequately powered to detect potentially subtle differences between the groups. Our study had 80% power to detect a true between-group IOP difference of 2.5 mmHg at 15 months with a two-sided alpha of 0.05. All patients treated at the hospital during the study period who met the inclusion criteria were recruited for this study. The final sample comprised 74 eyes from 44 patients divided into perforation (n = 31) and non-perforation (n = 43) groups based on exposure status.
Participants
Participants were eligible for the study if they met the following criteria: diagnosis of PCG, NPDS as planned as the first surgical procedure, age 0–15 months, and had at least six follow-up appointments for at least 15 months after surgery. The perforation group included patients who exhibited unmistakable signs of TDW perforation with or without iris prolapse. The exclusion criteria were prior glaucoma surgery, ocular trauma or infection, other significant ocular abnormalities, other forms of glaucoma, other ocular comorbidities affecting IOP, systemic diseases with ocular manifestations, patients outside the specified pediatric range, those with insufficient clinical data in their medical records, and those with < 15 months of postoperative follow-up. Studies have demonstrated that microperforation enhances the success of NPDS [32]; therefore, patients with microperforation were excluded from this study.
The cohorts’ baseline demographic and clinical characteristics included age, sex, procedure, family history, consanguinity, and the affected eye. In addition to demographic variables, various clinical characteristics were recorded, including surgery date, baseline IOP, horizontal corneal diameter, central corneal thickness, and transparency at the first follow-up after surgery. The patients underwent a comprehensive ophthalmological examination under anesthesia after admission, which included IOP measurement using an iCare IC200 (iCare Finland Oy, Vantaa, Finland) tonometer, corneal diameter measurements, portable slit-lamp examination of the anterior and posterior segments of the eye, ocular fundus examination, cycloplegic refraction, B-scan ultrasonography, axial length, and ultrabiomicroscopy (UBM). This multimodal approach enabled the complete assessment of ocular conditions. The intervention details were carefully documented, including the date of surgery, patient’s age at the time of surgery, surgical technique used, any intraoperative complications beyond perforation, occurrence of hypotony during the procedure, anterior chamber depth, iris prolapse, and whether iridectomy was performed.
Surgical Procedure
Deep sclerectomy was performed by consultants or fellows under the direct supervision of consultants. Corneal traction sutures were placed to expose the superior quadrant, and a limbal conjunctival incision was made. Mitomycin C (0.25 mg/ml) was applied to the subconjunctival space by using collagen sponges for 2 min. A 5 × 4-mm scleral superficial flap and a 4 × 3-mm deep flap were created. The deep flap was carefully dissected until it reached the SC, where spontaneous aqueous percolation was observed. The dissection was continued until a point 1.5 mm from the clear cornea was reached. The deep flap was cut, the superficial flap was loosely closed with two stitches in the corner areas using 10–0 nylon, and the conjunctiva was sutured continuously with 8–0 absorbable sutures. For cases where perforation of the TDW occurred with iris prolapse, iridectomy was performed, and the superficial flap was tightly closed. In cases where there was only mild or partial iris prolapse, with the TDW remaining partially intact, the iris was reduced using a thin spatula through paracentesis, an intracameral acetylcholine chloride intraocular solution (10 mg/ml; Miochol, Bausch & Lomb, Rochester, NY, USA) was injected, and iridectomy was avoided.
After surgery, patients were administered topical 1% prednisolone acetate and moxifloxacin antibiotics for at least 4 weeks. Postoperative check-ups were conducted to monitor patient recovery at 48 h, 1 month, and 3, 6, 9, and 15 months after surgery. During the follow-up period, data on the date of visit, anterior chamber depth, IOP, cycloplegic refraction, presence or absence of choroidal detachment, type and number of antiglaucoma medications used, and postoperative complications were recorded. All patients were evaluated under sedation provided by the dedicated sedation department at the KKESH. This department is staffed by a highly trained team of nurses, anesthesiologists, and pediatricians who follow strict protocols and guidelines for administering and monitoring sedation.
Statistical Analysis
Categorical variables are expressed as numbers and percentages; numerical variables are expressed as medians with their respective interquartile ranges [IQR]. Fisher’s exact test was used to analyze qualitative variables, and the Wilcoxon–Mann–Whitney test was used to analyze the differences between groups for continuous and non-normally distributed variables. Univariate and multivariate logistic regression analyses were used to evaluate possible correlations between perforation, iris prolapse, iridectomy, IOP, and other clinical and demographic variables. The results are presented as odds ratios (ORs) accompanied by a confidence interval of 95%. A Kaplan–Meier curve determined each group’s failure probability. Cox regression with the Breslow test was used to determine the discrepancies between the two groups regarding IOP during the follow-up period. Statistical significance was set at P < 0.05.
Results
The study group comprised 74 eyes of 44 patients who underwent deep sclerectomy; 31 eyes (42%) experienced intraoperative perforation. Bilateral deep sclerectomy was performed in 30 patients; five exhibited perforations in both eyes. The cohort comprised 31 perforated and 43 non-perforated eyes. The median [IQR] age was 19 (6–92) days in the perforation group and 37 (12–61) in the control group (P = 0.91). The follow-up period was 26 (19–37) months. Fellows operated on 48 eyes (65%); experienced consultants operated on 26 eyes (35%). Demographic and clinical findings are summarized in Table 1. Comparisons between the groups showed no significant differences in sex, affected eye, family history, consanguinity, mitomycin C use, paracentesis, age, horizontal corneal diameter, central corneal thickness, surgeon level, or axial length. In the perforation group, 18 of the 31 eyes (58%) had iris prolapse (Fig. 1). Iris prolapse occurred in 18 of the 31 perforated eyes (58%). We performed iridectomy in 16 eyes and reduced prolapse through paracentesis in two eyes. In the perforating group, 68% achieved complete success; 77% achieved the same success rate in the non-perforating group (P = 0.21). The qualified success rate was 19% in the perforating group and 9% in the non-perforating group (P = 0.18). The failure rate was 13% in the perforating group and 14% in the non-perforating group (P = 0.53); no significant differences were observed between the two groups for rates of complete success, qualified success, or failure (Fig. 2).
IOP was measured before and after treatment for the perforating and non-perforating procedures. The baseline IOP in the failure group had the widest distribution. After treatment, the IOP results were more consistent, as depicted by the narrow violin plot. Significant reductions in IOP after surgery were observed in both cohorts in the complete and qualified success groups (P < 0.001). Non-perforating procedures reduced IOP more than perforating procedures in the complete success group; these differences were not statistically significant (P = 0.68). Both cohorts showed no statistical differences in the baseline and final IOP, except for the baseline IOP in the perforation complete success group, which was greater than that in the non-perforation complete success group (P = 0.006). The lowest final IOP was observed with non-perforating procedures for complete success. Perforating and non-perforating IOP changes were comparable in cases of failure. Figure 3 shows the greater IOP reduction for complete and qualified success, with narrower violins showing treatment-normalizing IOP.
IOP measurements and reductions are shown as medians and interquartile ranges for the perforating (n = 31) and non-perforating (n = 43) procedures (Table 2). Non-perforating deep sclerectomy led to greater significant IOP reductions at all visits, with 54–74% lowering versus 46–68% with perforating surgery. The differences between the techniques were significant at the second follow-up (P = 0.03) but not others. In both groups, IOP decreased substantially from baseline after treatment (P < 0.001) and remained low throughout the follow-up visits. Although an IOP reduction of 2.7 mmHg greater was observed in the non-perforated group compared with the perforated group at 15 months, it was not statistically significant in the primary analysis (P = 0.12). Based on post hoc power analysis, our study was likely underpowered to conclude that the observed difference was statistically significant.
No significant association was found between the baseline IOP and the risk of intraoperative perforation (OR 0.95, 95% CI 0.89–1.01, P = 0.06). Intraoperative perforation was not significantly associated with IOP levels at the final follow-up visit (adjusted OR 0.95 per mmHg, 95% CI 0.89–1.05, P = 0.41). In unadjusted models, no significant link was found between IOP before or after surgery and the chances of perforation, iris prolapse, or the need for iridectomy. The unadjusted model found no evidence that preoperative or postoperative IOP affects the risk of these complications in pediatric glaucoma surgery. None of the p values for IOP were statistically significant (Table 3). For the IOP outcomes in the adjusted models, intraoperative TDW perforation was associated with a greater IOP at the final follow-up (OR 1.29 per mmHg increase, 95% CI 1.01–1.65; P = 0.04). Intraoperative perforation may lead to greater resistance to aqueous outflow over time, resulting in greater IOP at the final postoperative visit.
The last follow-up showed no significant connection between patients who had undergone iridectomy and those with greater IOP (OR 1.70, P = 0.06). No other baseline factors were significantly associated with surgical complications. Overall, the results suggest that greater pre- and postoperative IOP may increase the chances of requiring iridectomy when performing glaucoma surgery in pediatric patients.
In the Kaplan–Meier survival analysis (Fig. 4), non-perforating surgery showed a slightly greater probability of achieving a low IOP than perforating surgery at all time points. However, the difference between the survival curves was not statistically significant based on the Cox regression Breslow test (P = 0.67). Sixty-eight eyes (92%) showed no complications. During the procedure, four eyes (5%) had corneal perforation during traction suture placement. In addition, we noted one TDW was perforated with a cautery tip and one superficial flap buttonhole. In the immediate postoperative period, one eye (1%) in the perforation group presented with a shallow anterior chamber.
Discussion
Inadvertent macroperforation of the TDW during deep sclerectomy did not significantly affect IOP outcomes compared to non-perforated procedures. Both perforated and non-perforated deep sclerectomies were effective in reducing IOP.
Consistent with the findings of AlDarrab et al. and Elhofi et al., we found the IOP decreased after perforation. Notably, no significant differences were observed in IOP values between the perforation and non-perforation cohorts during NPDS [32, 33]. Kalala et al. reported that the perforating deep sclerectomy technique yielded results similar to those of traditional NPDS regarding efficacy and safety [27].
Our study found similar IOP values between the perforated and non-perforated groups. The discrepancy in baseline IOP between the perforation and non-perforation complete success groups was minimal, possibly attributed to the sample size or selection. The mechanisms involved in deep sclerectomy are intricate and exceed the scope of TDW. After the aqueous humor flows through the TDW, it collects in a scleral lake under the superficial scleral flap at the sclerectomy site. This scleral reservoir, which is an artificial space, may function as the first intrascleral filtration bleb [27]. ElSayyad et al. reported that some aqueous humor enters the suprachoroidal space, passes through the subconjunctival pathway, and reaches the filtration bleb [34]. A scleral flap can help regulate the aqueous outflow by providing resistance [35]. Episcleral venous drainage, conjunctival bleb, scleral channels, and suprachoroidal filtration are potential mechanisms for lowering IOP.
Over time, internal drainage pathways, including the intrascleral, TM, and suprachoroidal pathways, significantly reduce IOP. These pathways help regulate aqueous outflow resistance [36]. Deep sclerectomy reduces IOP by opening multiple channels for aqueous outflow. Even with a full-thickness opening of the TDW, the layered architecture of deep sclerectomy allows outflow through alternative routes. This architecture may explain why IOP reduction was similar between the perforated and non-perforated groups, even when the scleral flap was closed after perforation. The blended approach of macroperforation with iridectomy and tight flap closure preserves the architecture of deep sclerectomy, which may help avoid complications such as hypotony that can occur with trabeculectomy. This combined procedure may optimize safety and IOP reduction when managing intraoperative perforations. However, further research is needed to determine the ideal balance of techniques to maximize efficacy while minimizing adverse events.
The surgery outcome did not demonstrate any statistically significant difference regarding perforation (P = 0.06), regardless of whether it was performed by a fellow or expert; most procedures were conducted by fellows under close supervision. This finding is consistent with previous research, suggesting that surgeon experience is not associated with the outcomes of this procedure and may challenge the commonly held belief that difficulties are inevitable while learning NPDS with appropriate supervision [16].
Unlike adult procedures, our pediatric deep sclerectomy study did not involve intentional SC peeling. The nearly full-thickness dissection of the deep scleral flap may bypass the need to expose the SC separately. In children, the extreme thinness of the ocular tissues could allow deep flap creation alone to open the canal, precluding further manual peeling. We did not visualize an intact canal roof during surgery. The substantial flap dissection depth in pediatric eyes may eliminate the requirement for manual canal deroofing, which is typical in adults. Further research should investigate whether pediatric deep sclerectomy requires less canal manipulation because of deep flap formation and tissue thinness.
The most frequent complication during the surgery was corneal perforation at the time of traction suture placement. Viscoelastic use in the anterior chamber did not affect the final IOP in either group. This avoidable complication is common in surgeons with less experience with learning curves. Careful observation of the needle during the corneal passage, good magnification, and practice in wet-lab sessions can be beneficial to circumvent this unnecessary complication. No complications typically associated with trabeculectomy were observed during the procedure, including hyphema, choroidal, or retinal detachment.
One patient had a shallow anterior chamber in the immediate postoperative period. Despite TDW perforation, the safety profile of NPDS, as established in this study, is at least comparable to and likely superior to trabeculectomy. Our results indicate that deep sclerectomy is effective for reducing IOP in children with PCG, even if it results in intraoperative TDW macroperforation. Surgeons can proceed with deep sclerectomy as planned, even if inadvertent perforation occurs. The low complication rate after perforated deep sclerectomy suggests that it may be safer than trabeculectomy when managing intraoperative TDW macroperforations during pediatric glaucoma surgery. Therefore, deep sclerectomy can be considered a viable alternative to trabeculectomy. In summary, this study suggests that deep sclerectomy is effective and safe for reducing IOP in patients with PCG, even if it results in perforation.
Limitations
This study had a small sample size, but power analysis showed the ability to detect significant differences. The sample size was one of the largest for this rare population, given the scarcity of PCG and perforation after NPDS. This study provides valuable insights into the outcomes of this rare population, for which large, controlled, multicenter trials are unlikely. Standardized data collection was implemented to minimize potential biases, and systematic inclusion/exclusion criteria were applied to improve comparability. The study was from a single center, and multiple surgeons performed the procedure, limiting the generalizability of the results. Causality cannot be determined from association-based retrospective analyses, and these biases and limitations were considered when interpreting the results.
Conclusions
This investigation highlights that NPDS effectively decreases IOP in perforation and non-perforation groups of patients with PCG. Although differences in baseline IOP existed between the two groups, the variations in IOP and percentage reductions from baseline were comparable across the multiple follow-up periods. This finding supports that NPDS is a plausible and safe treatment option for reducing IOP in patients with PCG, regardless of whether perforation occurs.
Data Availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Badawi AH, Al-Muhaylib AA, Al Owaifeer AM, Al-Essa RS, Al-Shahwan SA. Primary congenital glaucoma: an updated review. Saudi J Ophthalmol. 2019;33:382–8. https://doi.org/10.1016/j.sjopt.2019.10.002.
Malik R, Khandekar R, Boodhna T, Rahbeeni Z, Al Towerki AE, Edward DP, et al. Eradicating primary congenital glaucoma from Saudi Arabia: the case for a national screening program. Saudi J Ophthalmol. 2017;31:247–9. https://doi.org/10.1016/j.sjopt.2017.08.002.
Badeeb OM, Micheal S, Koenekoop RK, den Hollander AI, Hedrawi MT. CYP1B1 mutations in patients with primary congenital glaucoma from Saudi Arabia. BMC Med Genet. 2014;15:109. https://doi.org/10.1186/s12881-014-0109-2.
Yazdani S, Miraftabi A, Pakravan M, Ghahari E, Tousi BK, Sedigh M, et al. Phenotype and genotype correlation in Iranian primary congenital glaucoma patients. J Glaucoma. 2016;25:33–8. https://doi.org/10.1097/IJG.0000000000000206.
Lee YJ, Ha A, Kang D, Shim SR, Jeoung JW, Park KH, et al. Comparative efficacies of 13 surgical interventions for primary congenital glaucoma in children: a network meta-analysis of randomized clinical trials. Int J Surg. 2023;109:953–62. https://doi.org/10.1097/JS9.0000000000000283.
Gagrani M, Garg I, Ghate D. Surgical interventions for primary congenital glaucoma. Cochrane eyes and vision group, editor. Cochrane Database Syst Rev. 2020. https://doi.org/10.1002/14651858.CD008213.pub3.
Stingl JV, Lagrèze WA, Hoffmann EM. Glaucoma in infancy and childhood Ophthalmologie. 2023;120:335–44. https://doi.org/10.1007/s00347-023-01828-2.
Al-Hazmi A, Awad AH, Zwaan J, Al-Mesfer SA, Al-Jadaan I, Al-Mohammed A. Correlation between surgical success rate and severity of congenital glaucoma. Br J Ophthalmol. 2005;89:449–53. https://doi.org/10.1136/bjo.2004.047761.
Mohammedsaleh A, Raffa LH, Almarzouki N, Jubran RM, Al-Harbi A, Alluqmani AH, et al. Surgical outcomes in children with primary congenital glaucoma: an eight-year experience. Cureus. 2020;12: e9602. https://doi.org/10.7759/cureus.9602.
Yassin SA, Al-Tamimi ER. Surgical outcomes in children with primary congenital glaucoma: a 20-year experience. Eur J Ophthalmol. 2016;26:581–7. https://doi.org/10.5301/ejo.5000784.
Yazdani S, Pakravan M, Gerami E, Doozandeh A, Esfandiari H, Sharifipour F. Trabeculotomy versus combined trabeculotomy-trabeculectomy for management of primary congenital glaucoma. J Glaucoma. 2022;31:346–50. https://doi.org/10.1097/IJG.0000000000001981.
Al-Obeidan SA, Osman EEA, Dewedar AS, Kestelyn P, Mousa A. Efficacy and safety of deep sclerectomy in childhood glaucoma in Saudi Arabia. Acta Ophthalmol. 2014;92:65–70. https://doi.org/10.1111/j.1755-3768.2012.02558.x.
Bhartiya S, Ichhpujani P, Shaarawy T. Surgery on the trabecular meshwork: histopathological evidence. J Curr Glaucoma Pract. 2015;9:51–61. https://doi.org/10.5005/jp-journals-10008-1184.
Roy S, Mermoud A. Deep sclerectomy. Dev Ophthalmol. 2017;59:36–42. https://doi.org/10.1159/000458484.
Morales J, Al Shahwan S, Al Odhayb S, Al Jadaan I, Edward DP. Current surgical options for the management of pediatric glaucoma. J Ophthalmol. 2013;2013: 763735. https://doi.org/10.1155/2013/763735.
Khan OA, Sesma G, Alawi A, AlWazae M. Outcomes of non-penetrating deep sclerectomy for primary congenital glaucoma performed by experienced versus trainee surgeons: a cohort study. Clin Ophthalmol. 2023;17:897–906. https://doi.org/10.2147/OPTH.S403016.
Rękas M, Rudowicz J, Lewczuk K, Kluś A, Pawlik B, Stankiewicz A. Phacoemulsification–deep sclerectomy modified by trabeculum microperforations and implantation of lens anterior capsule as autologous scleral implant. Curr Med Res Opin. 2010;26:2025–32. https://doi.org/10.1185/03007995.2010.500857.
Dietlein TS, Jacobi PC, Lüke C, Krieglstein GK. Morphological variability of the trabecular meshwork in glaucoma patients: implications for non-perforating glaucoma surgery. Br J Ophthalmol. 2000;84:1354–9. https://doi.org/10.1136/bjo.84.12.1354.
Lachkar Y, Neverauskiene J, Jeanteur-Lunel MN, Gracies H, Berkani M, Ecoffet M, et al. Nonpenetrating deep sclerectomy: a 6-year retrospective study. Eur J Ophthalmol. 2004;14:26–36. https://doi.org/10.1177/112067210401400105.
Kozobolis V, Kalogianni E, Sideroudi H. Penetrating deep sclerectomy in primary open-angle and pseudoexfoliative glaucoma. Eur J Ophthalmol. 2020;30:264–8. https://doi.org/10.1177/1120672119827768.
Shaarawy T, Nguyen C, Schnyder C, Mermoud A. Comparative study between deep sclerectomy with and without collagen implant: long-term follow-up. Br J Ophthalmol. 2004;88:95–8. https://doi.org/10.1136/bjo.88.1.95.
Suominen S, Harju M, Ihanamäki T, Vesti E. The effect of deep sclerectomy on intraocular pressure of normal-tension glaucoma patients: 1-year results. Acta Ophthalmol. 2010;88:27–32. https://doi.org/10.1111/j.1755-3768.2009.01623.x.
Papadopoulos M, Edmunds B, Fenerty C, Khaw PT. Childhood glaucoma surgery in the 21st Century. Eye (Lond). 2014;28:931–43. https://doi.org/10.1038/eye.2014.140.
Ambresin A, Shaarawy T, Mermoud A. Deep sclerectomy with collagen implant in one eye compared with trabeculectomy in the other eye of the same patient. J Glaucoma. 2002;11:214–20. https://doi.org/10.1097/00061198-200206000-00009.
Cheng JW, Xi GL, Wei RL, Cai JP, Li Y. Efficacy and tolerability of nonpenetrating filtering surgery in the treatment of open-angle glaucoma: a meta-analysis. Ophthalmologica. 2010;224:138–46. https://doi.org/10.1159/000236039.
Lüke C, Dietlein TS, Jacobi PC, Konen W, Krieglstein GK. Risk profile of deep sclerectomy for treatment of refractory congenital glaucomas. Ophthalmology. 2002;109:1066–71. https://doi.org/10.1016/s0161-6420(02)01077-1.
Kalala A, Gillmann K, Mermoud A. Prospective evaluation of penetrating deep sclerectomy in advanced open-angle glaucoma: filtration surgery adapted to resource scarcity in developing countries. J Fr Ophtalmol. 2020;43:228–36. https://doi.org/10.1016/j.jfo.2019.07.024.
Sanchez E, Schnyder C, Mermoud A. Résultats comparatifs de la sclérectomie profonde transformée en trabéculectomie et de la trabéculectomie classique. Klin Monatsbl Augenheilkd. 1997;210:261–4. https://doi.org/10.1055/s-2008-1035050.
Karaconji T, Mercieca K, Romera P, McNaught A, Anand N. A comparison of deep sclerectomy trainer versus trainee outcomes. J Glaucoma. 2019;28:427–32. https://doi.org/10.1097/IJG.0000000000001195.
Rulli E, Biagioli E, Riva I, Gambirasio G, De Simone I, Floriani I, et al. Efficacy and safety of trabeculectomy vs nonpenetrating surgical procedures: a systematic review and meta-analysis. JAMA Ophthalmol. 2013;131:1573–82. https://doi.org/10.1001/jamaophthalmol.2013.5059.
Sangtam T, Roy S, Mermoud A. Outcome and complications of combined modified deep sclerectomy and trabeculectomy for surgical management of glaucoma: a pilot study. Clin Ophthalmol. 2020;14:795–803. https://doi.org/10.2147/OPTH.S244945.
AlDarrab A, Malik R. Bilateral deep sclerectomy with microperforations as a successful secondary procedure in aniridia-associated glaucoma. Middle East Afr J Ophthalmol. 2018;25:52–5. https://doi.org/10.4103/meajo.MEAJO_291_17.
Elhofi A, Helaly HA. Non-penetrating deep sclerectomy versus trabeculectomy in primary congenital glaucoma. Clin Ophthalmol. 2020;14:1277–85. https://doi.org/10.2147/OPTH.S253689.
El Sayyad F, Helal M, El-Kholify H, Khalil M, El-Maghraby A. Nonpenetrating deep sclerectomy versus trabeculectomy in bilateral primary open-angle glaucoma. Ophthalmology. 2000;107:1671–4. https://doi.org/10.1016/s0161-6420(00)00263-3.
Correia Barbosa R, Gonçalves R, Bastos R, Alves Pereira S, Basto R, Viana AR, et al. Trabeculectomy vs non-penetrating deep sclerectomy for the surgical treatment of open-angle glaucoma: a long-term report of 201 eyes. OPTH Clin Ophthalmol. 2023;17:1619–27. https://doi.org/10.2147/OPTH.S405837.
Yan X, Zhang H, Li F, Ma L, Geng Y, Tang G. Surgical site characteristics after CLASS followed by ultrasound biomicroscopy and clinical grading scale: a 2-year follow-up. Eye (Lond). 2021;35:2283–93. https://doi.org/10.1038/s41433-020-01235-w.
Acknowledgements
We would like to express our sincere gratitude to Dr. Ibrahim AlObaida of the Glaucoma Division at King Khaled Eye Specialist Hospital for his valuable contributions to this manuscript. He provided insightful feedback and critiques that significantly improved the quality of this work. We also extend our appreciation to Dr. Ahmed Mousa of the Research Department at King Khaled Eye Specialist Hospital and Douglas Angulo of the Medicine Faculty at Universidad Central de Venezuela. Their expertise in statistical methods and data analysis was crucial in ensuring the validity and accuracy of the study results. We would also like to thank all the study participants for their support.
Medical Writing and Editorial Assistance
The authors acknowledge the medical writing services of Editage, a division of Cactus Communications, for copyediting and formatting the manuscript for submission. Editage was paid for by the authors. The authors also acknowledge the use of Claude AI by Anthropic and Scite.ai, which provided artificial intelligence tools for critical revisions of the manuscript. The authors themselves have interacted with the AI systems to generate the final manuscript.
Funding
No funding or sponsorship was received for this study or publication of this article. The authors funded the Rapid Service Fee.
Author information
Authors and Affiliations
Contributions
Abdulaziz AlQattan was responsible for the conceptualization, methodology, investigation, data curation, and writing of the original draft. Konrad Schargel contributed to the methodology, data curation, and writing—review and editing. Ibrahim AlJadaan was involved in the methodology, data curation, and supervision. Nouf AlZendi assisted with data curation and project administration. Gorka Sesma was responsible for the conceptualization, methodology, validation, writing—review and editing, and supervision.
Corresponding author
Ethics declarations
Conflict of Interest
Abdulaziz AlQattan, Konrad Schargel, Ibrahim AlJadaan, Nouf AlZendi, and Gorka Sesma declare that they have no competing interests.
Ethics Approval
This study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments, and was approved by the Institutional Review Board of King Khaled Eye Specialist Hospital (Protocol RP 23032-R). The requirement for informed consent was waived by the institutional review board as this is a retrospective study using de-identified data from existing medical records.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
About this article
Cite this article
AlQattan, A., Schargel, K., AlJadaan, I. et al. Effect of Trabeculodescemetic Window Perforation in Deep Sclerectomy on Intraocular Pressure in Primary Congenital Glaucoma. Ophthalmol Ther 13, 581–596 (2024). https://doi.org/10.1007/s40123-023-00869-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40123-023-00869-9